Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer's disease (AD). In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old) PS1(M146L)/APP(751SL) mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the axonal dystrophies, and by electron microscopic identification of numerous autophagic vesicles filling and causing the axonal swellings. Early neuritic cytoskeletal defects determined by the presence of phosphorylated tau (AT8-positive) and actin-cofilin rods along with decreased levels of kinesin-1 and dynein motor proteins could be responsible for this extensive vesicle accumulation within dystrophic neurites. Although microsomal Aβ oligomers were identified, the presence of A11-immunopositive Aβ plaques also suggested a direct role of plaque-associated Aβ oligomers in defective axonal transport and disease progression. Most importantly, presynaptic terminals morphologically disrupted by abnormal autophagic vesicle buildup were identified ultrastructurally and further supported by synaptosome isolation. Finally, these early abnormalities in axonal and presynaptic structures might represent the morphological substrate of hippocampal dysfunction preceding synaptic and neuronal loss and could significantly contribute to AD pathology in the preclinical stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The appearance of DNs is associated with problems with synaptic function, axonal transport, and inflammatory and oxidative stress pathways, making them the first sign of axonal damage before synaptic failure occurs in the early stages of AD [66].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disruption of autophagic flux and a failure of autophagosomes to fuse with lysosomes leads to a build-up of vesicles, which can be seen in dystrophic neurites and cell bodies in AD, CBD and PSP, as well as in tauopathy models73–76.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of dystrophic neurites is associated with impairments in synaptic function, axonal transport, and neuroinflammation, thereby serving as an early indicator of axonal damage prior to synaptic failure in the initial stages of AD (Sanchez-Varo et al. 2012).”
From Changes of the Primary Cilia in Alzheimer's Disease Pathogenesis (2025) · cites this paper as Sanchez-Varo et al. 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Axonal swelling, or spheroid, prominent in neuritic plaques, is formed by abnormal vesicular components in the axons [66, 68].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [66]
The cited source says what the claim attributes to it.
In the citing paper
“We observed a dramatic increase in the immunoblot signal ratio of LC3B-II to LC3B-I (~9-fold) in 5XFAD hippocampal homogenates (Fig. 10a, b), consistent with the accumulation of autophagic intermediates and a recent report also showing an increased LC3B-II: LC3B-I ratio in an APP transgenic [89].”
From The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques (2013) · cites this paper as [89]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundAlzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic loss in both the neocortex and the hippocampus is, so far, the best pathological correlate of early cognitive decline [19, 41, 52–54, 59, 61].”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588 · cited 2×
“Numerous autophagic vacuoles accumulate within dystrophic neurites in the brains of humans with AD and AD models [46, 47, 66] and several lines of investigation support the notion that defects in the autophagy process, a cellular catabolic mechanism essential for the degradation of aggregated proteins and organelles,…”
BackgroundSynaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 1×
“Whereas some authors have proposed that the appearance of dystrophic neurites precedes plaque formation [2, 23, 27, 56], a recent study using in vivo multiphoton imaging showed that dystrophies develop following amyloid deposition [42].”
BackgroundLee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212 · cited 2×
“Numerous autophagic vacuoles accumulate within dystrophic neurites in the brains of humans with AD and AD models [46, 47, 66] and several lines of investigation support the notion that defects in the autophagy process, a cellular catabolic mechanism essential for the degradation of aggregated proteins and organelles,…”
BackgroundBoland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119 · cited 1×
“Numerous autophagic vacuoles accumulate within dystrophic neurites in the brains of humans with AD and AD models [46, 47, 66] and several lines of investigation support the notion that defects in the autophagy process, a cellular catabolic mechanism essential for the degradation of aggregated proteins and organelles,…”
BackgroundHippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundRapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · cited 3×
“Whereas some authors have proposed that the appearance of dystrophic neurites precedes plaque formation [2, 23, 27, 56], a recent study using in vivo multiphoton imaging showed that dystrophies develop following amyloid deposition [42].”
BackgroundChishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“The presence of axonal dystrophies has been reported in AD patients in both early and late stages of the disease [7, 21, 22, 57] and also in another AD models [1, 8, 14, 20, 49, 64].”
BackgroundJin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876 · cited 2×
“Supporting the possible involvement of microtubule destabilization in AD pathogenesis, it has been recently reported [31] that natural oligomeric Ab, isolated from AD patients, disrupted the microtubule cytoskeleton and caused neuritic dystrophy (see also [67]).”
BackgroundKoffie, R. M., Meyer-Luehmann, M., Hashimoto, T., Adams, K. W., Mielke, M. L., Garcia-Alloza, M., Micheva, K. D., Smith, S. J., Kim, M. L., Lee, V. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811698106 · Cited by 850 · cited 1×
“Amyloid accumulation is considered a key event in AD pathology by causing glial activation, neuritic alteration, synaptic damage and neuronal death [34, 35, 42].”
BackgroundNeuropathology of Alzheimer's Disease
Perl, D. P. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20157 · Cited by 825
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundAutophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749 · cited 1×
“Numerous autophagic vacuoles accumulate within dystrophic neurites in the brains of humans with AD and AD models [46, 47, 66] and several lines of investigation support the notion that defects in the autophagy process, a cellular catabolic mechanism essential for the degradation of aggregated proteins and organelles,…”
BackgroundAltered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundZempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2357-10.2010 · Cited by 686 · cited 1×
“Supporting the possible involvement of microtubule destabilization in AD pathogenesis, it has been recently reported [31] that natural oligomeric Ab, isolated from AD patients, disrupted the microtubule cytoskeleton and caused neuritic dystrophy (see also [67]).”
BackgroundEndocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635
Autophagy failure in Alzheimer's disease—locating the primary defect
Nixon, R. A., & Yang, D.-S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.021 · Cited by 595 · cited 1×
“Numerous autophagic vacuoles accumulate within dystrophic neurites in the brains of humans with AD and AD models [46, 47, 66] and several lines of investigation support the notion that defects in the autophagy process, a cellular catabolic mechanism essential for the degradation of aggregated proteins and organelles,…”
BackgroundSZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundCastellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 519
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundTau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486 · cited 1×
“In fact, tau reduction prevents Ab-induced impairment of axonal transport [63].”
BackgroundPlasticity of Hippocampal Circuitry in Alzheimer's Disease
Geddes, J. W., Monaghan, D. T., Cotman, C. W., Lott, I. T., Kim, R. C., & Chui, H. C. (1985) · Science · doi:10.1126/science.4071042 · Cited by 461 · cited 1×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundMicrotubules Facilitate Autophagosome Formation and Fusion of Autophagosomes with Endosomes
Köchl, R., Hu, X. W., Chan, E. Y. W., & Tooze, S. A. (2006) · Traffic · doi:10.1111/j.1600-0854.2005.00368.x · Cited by 436 · cited 1×
“neurites [11, 33, 36].”
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432
Yang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429 · cited 4×
“The critical contribution of defective autophagy proteolytic clearance to the Ab pathology has been recently demonstrated in TgCRND8 transgenic mice [65].”
BackgroundResultInfluentialProbing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413 · cited 1×
“The expression of the human amyloid precursor protein (APP) with single or double mutations in transgenic mouse lines leads to the formation of neuritic plaques with clusters of dystrophic neurites and glial recruitment that resembles the amyloid pathology seen in AD brains [4, 28].”
BackgroundJimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383 · cited 7×
“The A11 or 6E10 immunoprecipitation experiments were also performed as described in detail previously [29, 30].”
BackgroundMethodResultSelf-citationIntraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338 · cited 1×
“Whereas some authors have proposed that the appearance of dystrophic neurites precedes plaque formation [2, 23, 27, 56], a recent study using in vivo multiphoton imaging showed that dystrophies develop following amyloid deposition [42].”
BackgroundLipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
Martins, I. C., Kuperstein, I., Wilkinson, H., Maes, E., Vanbrabant, M., Jonckheere, W., Van Gelder, P., Hartmann, D., D'Hooge, R., De Strooper, B., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601953 · Cited by 311 · cited 1×
“In support of this idea, amyloid fibrils, major component of amyloid plaques, can be destabilized and easily reverted to soluble and highly toxic Ab aggregates by biological lipids that are present in the brain [38] and, as mentioned above, GABAergic cells (that did not express hAPP and did not accumulated Ab peptides…”
BackgroundDickson, T. C., & Vickers, J. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00169-5 · Cited by 294 · cited 1×
“The presence of axonal dystrophies has been reported in AD patients in both early and late stages of the disease [7, 21, 22, 57] and also in another AD models [1, 8, 14, 20, 49, 64].”
BackgroundBlanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00252-8 · Cited by 283 · cited 1×
“The generation and characterization of PS1/APP transgenic (tg) mice has been reported previously [5, 10, 12, 29, 30, 44, 51].”
MethodYu, W. H., Kumar, A., Peterhoff, C., Shapiro Kulnane, L., Uchiyama, Y., Lamb, B. T., Cuervo, A. M., & Nixon, R. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.010 · Cited by 279 · cited 3×
“Numerous autophagic vacuoles accumulate within dystrophic neurites in the brains of humans with AD and AD models [46, 47, 66] and several lines of investigation support the notion that defects in the autophagy process, a cellular catabolic mechanism essential for the degradation of aggregated proteins and organelles,…”
BackgroundResultKanaan, N. M., Morfini, G. A., LaPointe, N. E., Pigino, G. F., Patterson, K. R., Song, Y., Andreadis, A., Fu, Y., Brady, S. T., & Binder, L. I. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0560-11.2011 · Cited by 272 · cited 1×
“Interestingly, it has been just reported that disease-associated changes in tau conformation inhibit kinesin-dependent axonal transport by modulating axonal phosphotransferases [32].”
BackgroundDecker, H., Lo, K. Y., Unger, S. M., Ferreira, S. T., & Silverman, M. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1074-10.2010 · Cited by 216 · cited 1×
“Soluble Ab oligomers have been shown to induce an increase in tau hyperphosphorylation [17, 31] as well as severe axonal transport failure and disruption of organelle trafficking through GSK3-beta signalling (manuscript in preparation;[18, 31]).”
BackgroundRamos, B., Baglietto-Vargas, D., Rio, J. C. D., Moreno-Gonzalez, I., Santa-Maria, C., Jimenez, S., Caballero, C., Lopez-Tellez, J. F., Khan, Z. U., Ruano, D., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.022 · Cited by 216 · cited 5×
“Western blots were performed as described previously [12, 29, 51].”
BackgroundMethodSelf-citationJimenez, S., Torres, M., Vizuete, M., Sanchez-Varo, R., Sanchez-Mejias, E., Trujillo-Estrada, L., Carmona-Cuenca, I., Caballero, C., Ruano, D., Gutierrez, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209718 · Cited by 188
Self-citationSeverely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., & Coleman, M. P. (2009) · Brain · doi:10.1093/brain/awn312 · Cited by 177 · cited 2×
“Supporting the idea that these changes could be potentially reversible, a recent study has reported that dystrophic axons surrounding amyloid plaques remain connected to viable neuronal bodies over a relatively long period of time [1].”
BackgroundImmunoelectron microscopic study of synaptic pathology in Alzheimer's disease
Masliah, E., Hansen, L., Albright, T., Mallory, M., & Terry, R. D. (1991) · Acta Neuropathologica · doi:10.1007/bf00293464 · Cited by 174 · cited 1×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundCytoskeletal pathologies of Alzheimer disease
Bamburg, J. R., & Bloom, G. S. (2009) · Cell Motility · doi:10.1002/cm.20388 · Cited by 171 · cited 1×
“These dystrophic neurites displayed tau phosphorylation (AT8positive) and actin–cofilin rods, and both alterations are known to alter cytoskeletal dynamics in neurons (revised in [6]).”
BackgroundKovács, A. L., Reith, A., & Seglen, P. O. (1982) · Experimental Cell Research · doi:10.1016/0014-4827(82)90020-9 · Cited by 163 · cited 1×
“neurites [11, 33, 36].”
Senile plaques as aberrant sprout-stimulating structures
Geddes, J. W., Anderson, K. J., & Cotman, C. W. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90254-2 · Cited by 161 · cited 1×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundKoenigsknecht-Talboo, J., Meyer-Luehmann, M., Parsadanian, M., Garcia-Alloza, M., Finn, M. B., Hyman, B. T., Bacskai, B. J., & Holtzman, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4147-08.2008 · Cited by 149 · cited 1×
“Amyloid accumulation is considered a key event in AD pathology by causing glial activation, neuritic alteration, synaptic damage and neuronal death [34, 35, 42].”
BackgroundNeurochemical Diversity of Dystrophic Neurites in the Early and Late Stages of Alzheimer's Disease
Dickson, T. C., King, C. E., McCormack, G. H., & Vickers, J. C. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7010 · Cited by 142 · cited 2×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundNimmrich, V., & Ebert, U. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.1.1 · Cited by 139
Altered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 139 · cited 1×
“The presence of axonal dystrophies has been reported in AD patients in both early and late stages of the disease [7, 21, 22, 57] and also in another AD models [1, 8, 14, 20, 49, 64].”
BackgroundMechanisms of amyloid plaque pathogenesis
Fiala, J. C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0284-8 · Cited by 113 · cited 1×
“Whereas some authors have proposed that the appearance of dystrophic neurites precedes plaque formation [2, 23, 27, 56], a recent study using in vivo multiphoton imaging showed that dystrophies develop following amyloid deposition [42].”
BackgroundZhang, X., Cai, Y., Xiong, K., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., & Yan, X. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07017.x · Cited by 108
Vitórica, J., & Satrústegui, J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90284-2 · Cited by 101 · cited 1×
“The synaptosomal fractions were obtained basically as described previously [62].”
MethodBaglietto-Vargas, D., Moreno-Gonzalez, I., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Romero-Acebal, M., Ruano, D., Vizuete, M., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100066 · Cited by 98
Self-citationIdentification and distribution of axonal dystrophic neurites in Alzheimer's disease
Su, J. H., Cummings, B. J., & Cotman, C. W. (1993) · Brain Research · doi:10.1016/0006-8993(93)91063-x · Cited by 97 · cited 3×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundPlaque biogenesis in brain aging and Alzheimer's disease
Su, J. H., Cummings, B. J., & Cotman, C. W. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00811-6 · Cited by 90
Su, J. H., Cummings, B. J., & Cotman, C. W. (1998) · Acta Neuropathologica · doi:10.1007/s004010050920 · Cited by 72 · cited 1×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundBell, K. F. S., de Kort, G. J. L., Steggerda, S., Shigemoto, R., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.027 · Cited by 70 · cited 1×
“The presence of axonal dystrophies has been reported in AD patients in both early and late stages of the disease [7, 21, 22, 57] and also in another AD models [1, 8, 14, 20, 49, 64].”
BackgroundNeuropathology of Alzheimer's Disease
Gómez‐Isla, T., Spires‐Jones, T. L., de Calignon, A., & Hyman, B. T. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01222-5 · Cited by 65 · cited 1×
“Accumulation of aggregated proteins at the extracellular (amyloid-beta, Ab) and intracellular (hyperphosphorylated tau) levels is one of the major abnormalities found in the brain of AD patients (revised in [13, 26, 50]).”
BackgroundDelatour, B., Blanchard, V, Pradier, L., & Duyckaerts, C. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.008 · Cited by 60 · cited 1×
“The presence of axonal dystrophies has been reported in AD patients in both early and late stages of the disease [7, 21, 22, 57] and also in another AD models [1, 8, 14, 20, 49, 64].”
BackgroundAD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly
Sokolow, S., Henkins, K. M., Bilousova, T., Miller, C. A., Vinters, H. V., Poon, W., Cole, G. M., & Gylys, K. H. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.011 · Cited by 58
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
Tampellini, D. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00013 · Cited by 54
Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
Masliah, E., Alford, M., Adame, A., Rockenstein, E., Galasko, D., Salmon, D., Hansen, L. A., & Thal, L. J. (2003) · Neurology · doi:10.1212/01.wnl.0000073987.79060.4b · Cited by 53 · cited 1×
“Dystrophic neurites are classically associated with compacted plaques in AD tissue [21, 24, 25, 39, 40, 57, 58] and these neuritic plaques have been considered to be a pathological correlation of dementia in AD patients [43].”
BackgroundAlzheimer’s disease as a disorder of dynamic brain self-organization
Arendt, T. (2004) · Progress in brain research · doi:10.1016/s0079-6123(04)47025-3 · Cited by 49 · cited 1×
“Whereas some authors have proposed that the appearance of dystrophic neurites precedes plaque formation [2, 23, 27, 56], a recent study using in vivo multiphoton imaging showed that dystrophies develop following amyloid deposition [42].”
BackgroundDystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging
Woodhouse, A., Vickers, J. C., Adlard, P. A., & Dickson, T. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.09.003 · Cited by 49 · cited 1×
“The presence of axonal dystrophies has been reported in AD patients in both early and late stages of the disease [7, 21, 22, 57] and also in another AD models [1, 8, 14, 20, 49, 64].”
BackgroundMoreno-Gonzalez, I., Baglietto-Vargas, D., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., del Rio, J. C., Torres, M., Romero-Acebal, M., Ruano, D., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1192 · Cited by 42 · cited 5×
“hippocampal formation of PS1/APP at 6 and 18 months of age (n = 4/age; 5 sections per animal) according to the optical fractionator method as previously described [44].”
BackgroundMethodSelf-citationNeuronal Death versus Synaptic Pathology in Alzheimer's Disease
Bertoni–Freddari, C., Fattoretti, P., Solazzi, M., Giorgetti, B., Stefano, G. D., Casoli, T., & Meier-Ruge, W. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.116 · Cited by 34 · cited 1×
“The presence of morphologically disrupted presynaptic terminals may be one of the initial stages for synaptic loss and dysfunction, so far the best correlate for early symptoms in AD patients [3, 9, 19, 41, 45, 52, 53, 59, 61] and, therefore, a pre-clinical manifestation of progression of the disease.”
BackgroundNoda-Saita, K., Terai, K., Iwai, A., Tsukamoto, M., Shitaka, Y., Kawabata, S., Okada, M., & Yamaguchi, T. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0907-2 · Cited by 31
Caballero, C., Jiménez, S., Moreno‐González, I., Baglietto‐Vargas, D., Sanchez-Varo, R. M., Gavilán, M. P., Ramos, B., del Río, J. C., Vizuete, M., Gutiérrez, A., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21172 · Cited by 12
Self-citationHussain, I. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791556087 · Cited by 6 · cited 1×
“The expression of the human amyloid precursor protein (APP) with single or double mutations in transgenic mouse lines leads to the formation of neuritic plaques with clusters of dystrophic neurites and glial recruitment that resembles the amyloid pathology seen in AD brains [4, 28].”
Background
Cited by
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718
Dark microglia: A new phenotype predominantly associated with pathological states
Bisht, K., Sharma, K. P., Lecours, C., Gabriela Sánchez, M., El Hajj, H., Milior, G., Olmos‐Alonso, A., Gómez‐Nicola, D., Luheshi, G., Vallières, L., et al. (2016) · Glia · doi:10.1002/glia.22966 · Cited by 421
“6F) as previously described in AD models (Francois et al., 2014; Sanchez-Varo et al., 2012).”
MethodSalminen, A., Kaarniranta, K., Kauppinen, A., Ojala, J., Haapasalo, A., Soininen, H., & Hiltunen, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.002 · Cited by 364
Boza-Serrano, A., Ruiz, R., Sanchez-Varo, R., García-Revilla, J., Yang, Y., Jimenez-Ferrer, I., Paulus, A., Wennström, M., Vilalta, A., Allendorf, D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02013-z · Cited by 357
Self-citation
Metadata
- Authors
- Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., Davila, J. C., Garcia-Verdugo, J. M., Jimenez, A. J., Vitorica, J., & Gutierrez, A.
- Affiliations
- Universidad de Málaga (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- Acta Neuropathologica
- Published
- 2011-10-22
- Volume
- 123
- Issue
- 1
- Pages
- 53-70
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3249205
- OpenAlex
- W2001428953
- Cited by
- 222
- References
- 70
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 12 · 2023: 19 · 2022: 20 · 2021: 17 · 2020: 14 · 2019: 21 · 2018: 20 · 2017: 15 · 2016: 12 · 2015: 9 · 2014: 16 · 2013: 14 · 2012: 5
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- idUS (Universidad de Sevilla) (publishedVersion, cc-by-nc-nd)
- Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, public-domain)
- Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by-nc)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- Funders
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Instituto de Salud Carlos III
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, autophagic vesicles, autophagy, axonal dystrophy, neuritic plaques, amyloid-beta oligomers, presynaptic terminals, synaptic dysfunction, LC3, tau phosphorylation, kinesin-1, dynein motor, axonal transport, hippocampus, preclinical Alzheimer's disease, dystrophic neurites
- MeSH terms
- Alzheimer Disease, Animals, Autophagy, Axons, Disease Models, Animal, Hippocampus, Mice, Transgenic, Neurons, Microscopy, Immunoelectron, Neurites, Amyloid beta-Protein Precursor, Presynaptic Terminals, Cytoplasmic Vesicles, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.